Medicinal Chemistry Research
sulfadoxine. It is possible to conclude that the 1H-pyrazolo
[3,4-d]pyrimidine system is promising as a prototype for
further studies of antimalarial candidates with the objective
of overcoming the burden of resistance in P. falciparum.
Kaur K, Jain M, Reddy RP, Jain R (2010) Quinolines and structurally
related heterocycles as antimalarials. Eur
J Med Chem
45:3245–3264
Lambros C, Vanderberg JP (1979) Synchronization of Plasmodium
falciparum erythrocytic stages in culture. J Parasitol 65:418–420
Mushtaque M, Shahjahan (2015) Reemergence of chloroquine (CQ)
analogs as multi-targeting antimalarial agents: A review. Eur J
Med Chem 90:280–295
Noedl H, Wongsrichanalai C, Miller RS, Myint KSA, Looareesuwan
S, Sukthana Y, Wongchotigul V, Kollaritsch H, Wiedermann G,
Wernsdorfer WH (2002) Plasmodium falciparum: effect of anti-
malarial drugs on the production and secretion characteristics of
histidine-rich protein II. Exp Parasitol 102:157–163
Acknowledgements We thank the Coordination of Improvement of
Higher Education (CAPES) and the National Council of R&D of
Brazil (CNPq) for the fellowships granted to the authors. We also
thank the Foundation for Research of the State of Rio de Janeiro
(FAPERJ), Technological Development Program on Products for
Health (PDTIS), for financial support. LJMC, LCSP and NB are
recipients of research productivity fellowships from the CNPq and
from FAPERJ (“Cientista do Nosso Estado”).
Pinheiro LCS, Boechat N, Ferreira MLG, Junior CCS, Jesus AML,
Leite MMM, Souza N, Krettli AU (2015) Anti-Plasmodium fal-
ciparum activity of quinoline–sulfonamide hybrids. Bioorg Med
Chem 23:5979–5984
Compliance with ethical standards
Santos MS, Bernardino AMR, Pinheiro LCS, Canto-Cavalheiro MM,
Leon LL (2012) An efficient synthesis of new 5‐(1‐Aryl‐1H‐
pyrazole‐4‐yl)‐1H-tetrazoles from 1‐Aryl‐1H‐pyrazole‐4‐carbo-
nitriles via [3 + 2]Cycloaddition reaction. J Heterocycl Chem
49:1425–1428
Conflict of interest The authors declare that they have no conflict of
interest.
Schrader FC, Barho M, Steiner I, Ortmann R, Schlitzer M (2012) The
References
antimalarial pipeline-an update. Int
J
Med Microbiol
302:165–171
Anthony MP, Burrows JN, Duparc S, JMoehrle J, Wells TNC (2012)
The global pipeline of new medicines for the control and elim-
ination of malaria. Malar J 11:316
Azeredo LFSP, Coutinho JP, Jabor VAP, Feliciano PR, Nonato MC,
Kaiser CR, Menezes CMS, Hammes ASO, Caffarena ER, Hoelz
LVB, Souza NB, Pereira GAN, Ceravolo IP, Krettli AU, Boechat
N (2017) Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines
as anti-Plasmodium falciparum, antimalarial, and Pf-
dihydroorotate dehydrogenase inhibitors. Eur J Med Chem
126:72–83
Silva TB, Bernardino AMR, Ferreira MLG, Rogerio KR, Carvalho
LJM, Boechat N, Pinheiro LCS (2016) Design, synthesis and
anti-P. falciparum activity of pyrazolopyridine–sulfonamide
derivatives. Bioorg Med Chem 24:4492–4498
Soliman AM, Sultan AA, El Remaily MAA, Abdel-Ghany H (2012)
Synthesis of some novel fused azole derivatives. Synth Comm
42:2748–2762
́
Teixeira C, Vale N, Perez B, Gomes A, Gomes JRB, Gomes P (2014)
“Recycling” classical drugs for malaria. Chem Rev
114:11164–11220
Tilley L, Straimer J, Gnädig NF, Ralph SA, Fidock DA (2016)
Artemisinin action and resistance in Plasmodium falciparum.
Trends Parasitol 32:682–696
Barnett DS, Guy RK (2014) Antimalarials in development in 2014.
Chem Rev 114:11221–11241
Bernardino AMR, Pinheiro LCS, Rodrigues CR, Loureiro NI, Castro
HC, Lanfredi-Rangel A, Sabatini-Lopes J, Borges JC, Carvalho
JM, Romeiro GA, Ferreira VF, Frugulhettic ICPP, Vannier-
Santos MA (2006) Design, synthesis, SAR, and biological eva-
luation of new 4-(phenylamino)thieno[2,3-b]pyridine derivatives.
Bioorg Med Chem 14:5765–5770
Biamonte MA, Wanner J, Le Roch KG (2013) Recent advances in
malaria drug discovery. Bioorg Med Chem Lett 23:2829–2843
Boechat N, Ferreira MLG, Pinheiro LCS, Jesus AML, Leite MMM,
Aguiar ACC, Andrade IM, Krettli AU (2014) New compounds
hybrids 1H-1,2,3-triazole-quinoline against Plasmodium falci-
parum. Chem Biol Drug Des 84:325–332
Boechat N, Pinheiro LCS, Silva TS, Aguiar ACC, Carvalho AS,
Bastos MM, Costa CCP, Pinheiro S, Pinto AC, Mendonça JS,
Dutra KDB, Valverde AL, Santos-Filho OA, Ceravolo IP, Krettli
AU (2012) New trifluoromethyl triazolopyrimidines as anti-
Plasmodium falciparum agents. Molecules 17:8285–8302
Carvalho RCC, Martins WA, Silva TP, Kaiser CR, Bastos MM, Pin-
heiro LCS, Krettli AU, Boechat N (2016) New pentasubstituted
pyrrole hybrid atorvastatin–quinoline derivatives with anti-
plasmodial activity. Bioorg Med Chem Lett 26:1881–1884
Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and
survival. Modifications to the tetrazolium dye procedure giving
Trager W, Jensen JB (1976) Human malaria parasites in continuous
culture. Science 193:673–675
Vandekerckhove S, D’hooghe M (2015) Quinoline-based antimalarial
hybrid compounds. Bioorg Med Chem 23:5098–5119
Varotti FP, Botelho ACC, Andrade AA, Paula RC, Fagundes EMS,
Valverde A, Mayer LMU, Mendonca JS, Souza MVN, Boechat
N, Krettli AU (2008) Synthesis, antimalarial activity, and intra-
cellular targets of MEFAS, a new hybrid compound derived from
mefloquine and artesunate. Antimicrob Agents Chemother
52:3868–3874
Wells TN, Hooft van Huijsduijnen R, Van Voorhis WC (2015)
Malaria medicines: a glass half full? Nat Rev Drug Discov
14:424–442
White NJ (2004) Antimalarial drug resistance.
J Clin Invest
113:1084–1092
World Health Organization (WHO) (2015) Guidelines for the Treat-
World Health Organization (WHO) (2017) World Malaria Report
improved sensitivity and reliability.
J Immunol Methods
89:271–277